Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.8%

4 terminated/withdrawn out of 41 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

4%

1 of 28 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
31(77.5%)
Phase 2
5(12.5%)
Phase 1
3(7.5%)
Phase 3
1(2.5%)
40Total
N/A(31)
Phase 2(5)
Phase 1(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials
NCT07466485Phase 2Not Yet Recruiting

The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)

Role: collaborator

NCT07541300Not ApplicableActive Not Recruiting

The Effects of Palm Olein and Palm Kernel Oil Diets on Gut Hormones and Appetite in Healthy Adults

Role: lead

NCT04156503Not ApplicableCompleted

Pilot Study-Quantitative Analysis of Positional Fatty Acids in Postprandial Chylomicron Triacylglycerol Using 13C NMR Spectroscopy

Role: lead

NCT02581085Phase 2Active Not Recruiting

Tocotrienol Against the Progression of End Stage Liver Disease

Role: collaborator

NCT03256123Not ApplicableCompleted

The Effects of Biscuits Containing Red Palm Oil on School Children With Vitamin A Deficiency in West and East Malaysia

Role: lead

NCT02924896Not ApplicableCompleted

Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation

Role: collaborator

NCT05787743Not ApplicableTerminated

Topical Palm Tocotrienols on Skin Biophysical Properties

Role: collaborator

NCT05756881Not ApplicableTerminated

Topical Palm Tocotrienols on Blemish-prone Skin

Role: collaborator

NCT05977244Not ApplicableUnknown

Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model

Role: lead

NCT05791370Not ApplicableCompleted

Red Palm Olein on Inflammation and Gut Health

Role: lead

NCT00753532Phase 2Completed

Neuroprotective and Cardioprotective Effects Of Palm Vitamin E Tocotrienols

Role: collaborator

NCT04573218Phase 2Completed

Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia

Role: collaborator

NCT02532088Phase 1Withdrawn

Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes

Role: collaborator

NCT01858311Completed

Nutrition Blood Outcomes Following Tocotrienol N2B

Role: collaborator

NCT02913690Not ApplicableUnknown

Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH)

Role: collaborator

NCT02230800Phase 2Completed

PPALM-Palm Oil and Pentoxifylline Against Late Morbidity

Role: collaborator

NCT04164446Phase 1Unknown

Supplementation of Oil Palm Phenolics to Healthy Participants

Role: collaborator

NCT02897674Not ApplicableCompleted

Effect of Palm Olein Intake on Lipid Profile and Fat Deposition

Role: collaborator

NCT03855423Not ApplicableUnknown

Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer

Role: collaborator

NCT03532763Not ApplicableUnknown

Anti-Inflammatory Effect of Tocotrienol Supplementation in Subjects With Moderately Elevated Inflammation

Role: lead